Serum lead concentrations measured by stable isotope dilution with a thermal ionization mass spectrometer and blood lead concentrations measured by graphite furnace atomic absorption spectrophotometry are reported for 73 women of child bearing age resident in Los Angeles, California. The two quantities are related by the line y ‫؍‬ 0.00030 ؉ 0.00241x (r ‫؍‬ 0.83), where y is serum lead concentration and x is blood lead concentration, both being expressed in units of g/L. The linearity of the relationship appears to hold to a blood lead concentration of at least 60 g Pb/L. The slope of the line indicates that lead in serum is 0.24% of that in whole blood in contrast to recent reports of between 0.32 and 0.35% determined by inductively coupled plasma (ICP) mass spectrometry with bismuth used as an internal standard. The discrepancy stems from the ICP mass spectrometer-generated curves not passing through the origin.
INTRODUCTION
To determine elemental concentrations in the range of parts per million to parts per billion the closest approach to an absolute measurement is stable isotope dilution. The assay has most frequently been performed by thermal ionization mass 1 This work was supported by a cooperative agreement for Substance-Speci7c Research Program Grant No. U50/ATU398948 with the Agency for Toxic Substances and Disease Registry, CDC and the Minority Health Professions Foundation but does not necessarily represent the views of those organizations. Additional support was obtained from P20-RR11145 NIH/RCMI. The procedures and consent forms were reviewed and approved by the King/Drew Medical Institutional Review Board. 2 To whom correspondence should be addressed at Department of Geology, Mail Drop FO21, University of Texas at Dallas, P. O. Box 830688, Richardson, 883-2537. spectrometry with the disadvantage that a laborious chemical separation has to be performed before the sample can be analyzed and the limitation that monisotopic elements and those with high ionization potentials are excluded. In recent years mass spectrometers equipped with inductively coupled plasma (ICP) sources have come on the market and appear to offer useful advantages: (1) the plasma ionizes all the elements; (2) the ef7ciency of ionization is a uniform 20%, which leads to high sensitivities; (3) there is no mass fractionation in the source; (4) the sample has only to be dissolved because the temperature of the plasma breaks down all compounds and mass 7lters separate the ions of the element from those of the matrix by physical rather than by chemical properties; (5) the elimination of chemical separations has the potential of lowering detection limits by reducing the blank correction; and (6) the method has the potential of high throughput (Halliday, 1997) .
This paper is concerned with the analysis of lead in blood plasma or blood serum by mass spectrometry. Whereas there seems to be no difference in the lead content of blood plasma and blood serum, the words cannot be used interchangeably because the 8uid in the living person is always plasma but the 8uid obtained after blood has clotted is serum. In this paper we shall use the term plasma to refer to the 8uid in the living body and to any 8uid obtained by the centrifugation of blood to which an anticoagulant has been added. We shall use the term serum for the 8uid obtained by the centrifugation of blood to which no anticoagulant has been added irrespective of whether clotting has occurred.
Two papers reporting the concentrations of lead in blood plasma by ICP mass spectrometry have been recently published (Schu K tz et al., 1996; HernandezAvila et al., 1998) . Neither group of investigators, however, used true isotope dilution in which an enriched stable isotope of lead was added to the sample. Instead, both groups added as an internal standard bismuth, which is monisotopic and adjacent to lead in the periodic table, and made the assumptions that both elements behave identically in the plasma and that the bismuth content of blood plasma is negligible. They used different instruments: Schu K tz et al. (1996) used a PlasmaQuad (VG Elemental) having a quadrupole mass 7lter and Hernandez- Avila et al. (1998) used a Finnigan Element (Finnigan Instruments) with much higher resolution, being equipped with tandem magnetic and electrostatic, i.e., momentum and energy, 7lters. Both groups showed that the plasma lead to blood lead relationship is curvilinear, but there were signi7cant differences in technique and 7ndings. Schu K tz et al. (1996) apparently used reagents uncerti7ed as to lead content, did not process their samples in a clean room, and reported no analytical blanks. They claimed that hemolysis had little effect on the amount of lead found in blood plasma, a claim reiterated in a recent paper from the same laboratory (Bergdahl et al., 1999) . Hernandez-Avila et al. (1998) , on the other hand, used clean techniques and claimed that iron had to be measured in every sample to avoid measurements being biased by occult hemolysis . Although the curves of lead in blood plotted against lead in plasma reported by each group differed fundamentally, with Hernandez-Avila et al.'s (1998) being curved in loglog space and Schu K tz et al. 's (1996) being linear in log-linear space, their plots of the fraction of lead in plasma against blood lead were linear with almost identical slopes and intercepts (Bergdahl and Skerfving, 1997; Hernandez-Avila et al., 1998) . Furthermore, the logarithmic functions used by both groups, though mathematically consistent with their measurements, are not describing reality because by their very nature they cannot pass through the origin and so defy the axiom that the lead content of plasma will be zero when that of blood is zero.
Both groups' results differed from those of an earlier study by Manton and Cook (1984) who had measured lead in blood serum by stable isotope dilution and the thermal ionization method. These authors found that a plot of serum lead against blood lead did not pass through the origin and indicated a serum lead of about 0.6 g/L for a blood lead of zero. Neither Schu K tz et al. (1996) nor HernandezAvila et al. (1998) observed such high concentrations in plasma, leading Schu K ltz et al. (1996) to ascribe Manton and Cook's (1984) high values to contamination, but Smith et al. (1998) produced evidence that when blood is allowed to stand and clot there is a continuous release of lead from the clot to the serum and raised the possibility that Manton and Cook's (1984) observations arose from such disequilibrium. Not having considered clotting time a factor, Manton and Cook (1984) made no attempt to control it. They instead explained their high values by the failure of lead ingested from food to immediately bind to the red cells and, chie8y on the basis of a number of measurements on a fasting subject, postulated that the equilibrium curve of serum lead against blood lead passes through the origin, a serum lead concentration of 0.20 g/L at a blood lead of 100 g/L, and a serum lead concentration of 2.0 g/L at a blood lead of 500 g/L. This curve lies below the curves of Schu K tz et al. (1996) and Hernandez-Avila et al. (1998) , both of which indicate a plasma lead concentration of 0.37 g/L at a blood lead of 100 g/L.
The diverse and sometimes contradictory 7ndings of these three studies prompted us to report here part of a wider study (Rothenberg et al., 1999a (Rothenberg et al., ,b, 2000 investigating various health effects of lead peculiar to pregnancy. The laboratory and the techniques are essentially those of Manton and Cook (1984) . Whereas the blood leads encountered today are more than 10-fold lower than those of 20 years ago, the availability of cleaner reagents, especially water, has allowed the laboratory blank to be lowered by a factor of 500, so that lead concentrations as low as 0.015 g Pb/L in serum can be measured in a 3-mL sample.
SUBJECTS
The subjects were residents of Los Angeles who participated in the Lead and Blood Pressure during Pregnancy project being conducted at the Charles R. Drew University of Medicine and Science. The aim of the primary study is to analyze serum from the subjects during and after pregnancy, but a number did not return for the second drawing. Their samples, which normally would be discarded, were pooled to make a reference sample.
To avoid the bias introduced by the physiologic anemia of pregnancy we report here only samples taken after delivery. About 70% of the 73 subjects were immigrants from Latin America. Their ages ranged from 16 to 47 years with a mean of 29 years. The average number of pregnancies was three with 27% of the subjects having been pregnant for the 7rst time. At the time of venipuncture, which averaged 12 weeks from delivery, 35 were breast feeding and 35 were not. The status of the other 3 was not recorded.
METHODS

Choice of Serum over Plasma
We chose not to analyze plasma on account of the large blanks associated with commercially available heparinized collection tubes, which we found could contribute 300 to 800 pg of lead to the sample. By analyzing serum we could reduce the collection blank to about 12 pg contributed by the polypropylene syringe and 1 to 2 pg by the polypropylene centrifuge tube.
Blood
After thorough cleansing of the skin with alcohol and distilled water, blood was taken by syringe through a 12-gauge Vacutainer butter8y assembly. The 7rst 3 to 5 mL was transferred into a blue-top (''trace metal-free'') Vacutainer containing heparin. The lead content was measured by the graphite furnace technique on a Perkin}Elmer 4100ZL atomic absorption spectrophotometer in the Toxicology Laboratory of Drew University, which successfully participates in the Centers for Disease Control and the College of American Pathologists' blood lead quality assurance programs.
As we expected that the error associated with the analysis of lead in serum would be large, perhaps as high as 15 to 30%, we felt it suf7cient to measure blood lead by the graphite furnace technique. It would have been pointless to measure blood lead by the highly accurate (0.1% at the concentrations encountered in whole blood) but expensive and time-consuming method of thermal ionization mass spectrometry.
Serum
After the sample had been taken for whole blood analysis a further 7 mL of blood was drawn into a second syringe and transferred to a polypropylene culture tube, capped, and immediately centrifuged at 800g for precisely 15 min. The supernatant serum was transferred to a 15-mL Te8on PFA jar and was frozen at !70@C until shipped to the University of Texas at Dallas for analysis. All handling of blood and serum was done under Class 100 conditions.
With the exception of butter8ies and syringes which were assumed clean, the equipment for collecting serum was cleaned in the Dallas laboratory. Polypropylene culture tubes and pipette tips were cleaned in acetone, hydrochloric acid, and water as has been described elsewhere (Manton et al., 2000) . The 15-mL Te8on jars used for storage served also as decomposition vessels and, being newly purchased, were potential sources of lead contamination. They were cleaned by autoclaving for 4 days at 200@C in distilled nitric acid.
Step-wise leaching experiments had shown that after this length of time and at this temperature less than 1 pg Pb is released from the Te8on every 24 h.
The samples were spiked with 1.5 ng of a pure
206
Pb spike before being decomposed on a hot plate by boiling in distilled nitric acid. Lead was separated in two ion exchange steps (Manton et al., 2000) . To minimize the blank the smallest possible volumes of reagents were used and the step of centrifuging the sample before loading on the ion exchange column was omitted. Samples were evaporated in tanks under 7ltered air and all other handling of the samples was done at Class 100 work stations.
The concentration of lead was calculated from the Pb) which appears in the denominator of the equation used to calculate the concentration. It was to minimize the effect of this error that we chose to spike with 1.5 ng of 206 Pb because for the largest sample its effect would be at most 5%. For a 7xed amount of spike this source of error will decrease with decreasing amounts of lead in the sample, as opposed to the analytical blank correction which will increase with decreasing amounts of sample lead.
As it was known from earlier work that the blood leads encountered in this study would with few exceptions be less than 50 g/L, serum leads were expected to be less than 0.1 g/L (Manton and Cook, 1984) , which meant that a 3-mL sample would contain 300 pg or less of lead. At these levels the blank correction becomes a large proportion of the lead processed, and if the lowest concentrations were to be measured with any con7dence the blank had to be accurately known. The blank falls into two parts, that associated with sample collection and that associated with sample analysis. The former, we have indicated, is probably less than 15 pg and, as more than 99% of it is immediately bound to the red cells (Manton and Cook 1984) , it is small enough to be ignored (Schu K tz et al., 1996; Hernandez-Avila et al., 1998). To estimate the analytical blank we prepared a 350-mL reference sample of serum by combining samples taken from the 112 women that had not returned for a second blood drawing and found that it contained approximately 0.05 g Pb/L. We then spiked two 60-mL portions with 205 Pb. This spike allows for concentration and isotope ratios to be measured simultaneously, and we used the latter as a measure of the ratios of the population. After correcting for the blank, which was largely the lead contained in the acid, we obtained concentrations closely agreeing at 0.0496 and 0.0497 g Pb/L. We then spiked 48 portions, each 3 mL, of the composite sample with 206 Pb and calculated the blank as the difference between the lead found and the lead known to be in each sample. The spike has a 208 Pb/ 206 Pb ratio of 0.000081 and in the quantity used can reliably detect 0.1 pg Pb.
To investigate hemolysis we analyzed for lead and iron 18 samples of serum that ranged in color from the palest yellow to those obviously tinged with pink. For measurement of iron, aliquots of the decomposed serum samples were diluted and analyzed on a Perkin}Elmer Optima 3000 ICP atomic emission spectrometer. The standard was prepared from high-purity metal and was stabilized in hydrochloric acid. For a reference sample, we used a composite of monkey plasma whose iron content we had measured by thermal ionization mass spectormetry after spiking with 57 Fe. We investigated the effect of clotting time only as it pertained to interpretation of Manton and Cook's (1984) study. The subject was the same as had participated in the fasting portion of that study and, as before, underwent a 36-h fast over the last 24 h of which urine was collected. Two 25-mL samples of blood were drawn by syringe and transferred to centrifuge tubes. One sample was centrifuged immediately and the other after being left to clot for 5 h 30 min. Each yielded 8 mL of serum. The needles and syringes were from the same batch used by Manton and Cook (1984) , and, like theirs, the centrifuge tubes were Pyrex.
RESULTS
Blanks
In Fig. 1 we show a histogram of the blanks determined from replicate measurements of the bulk serum sample. The distribution has a well-de7ned mode between 15 and 20 pg Pb and an overall lognormal form. The geometric mean and standard deviations are 18> 14 / \ 8 pg Pb and the 95% con7dence limits are $3 pg Pb. The apparent lack of asymmetry in the latter stems from rounding. The rather large standard deviations and the lognormality are to be expected since the blank re8ects the contamination contributed by each of the three independent processes involved in the chemical separation of the lead, i.e., the steps of decomposition and evaporation, ion exchange, and single bead separation.
Hemolysis
In Table 1 we show iron and lead concentrations for serum samples of various colors and the associated whole blood lead concentrations. In visibly unhemolyzed samples iron ranged from 0.3 to 1.0 g/mL and even in samples tinged with pink iron was still in the normal range of 0.5 to 1.75 g/mL cited by Hernandez-Avila et al. (1998) . It seems that the deepness of the color of plasma is a function of its iron content, but the range is so large that a hemolyzed pale yellow sample contains no more iron than an uncontaminated deep yellow sample. Only in the badly hemolyzed sample was iron elevated. The ratio of plasma lead to blood lead is modestly elevated in the hemolyzed samples, as was found by Schu K tz et al. (1996) .
Effect of Clotting Time
The subject used to evaluate the effect of clotting time on the lead content of serum had a blood lead Pb ratio of blood was 1.1617 and that of urine was 1.1588.
B Serum from a blood sample drawn consecutively to the previous draw.
concentration of 58.9 g/L. In the sample that had been centrifuged immediately the serum lead concentration was 0.15 g/L, leading to a ratio of serum lead to blood lead of 0.25% and a renal clearance of 14 mL/min (Table 2 ). In the sample left standing for 5 h and 30 min the lead concentration of the serum decreased to 0.072 g Pb/L. This 7nding is the opposite of Smith et al.'s (1998) who reported that the lead content of serum left to clot in Te8on tubes increased from 0.2 to 1.2% of the blood lead concentration over a period of 70 min.
Serum Pb and Blood Pb Concentrations
The blood lead concentrations of the 73 subjects reported here ranged from 6 to 126 g/L. Ten of these were greater than 40 g/L and of the remainder half were less than or equal to 20 g/L. Serum lead concentrations after correction for the blank ranged from 0.014 to 0.34 g/L with a mean of 0.066 g/L. For the lowest concentrations the blank was one-third of the amount of lead processed.
Relation of Serum Pb to Blood Pb
We plotted independently the results from the lactating and the nonlactating women and found that the lines 7tted to each group were indistinguishable once outliers that unduly in8uenced each line were omitted. We therefore pooled the results from all the subjects and show in Fig. 2 their serum leads plotted against their blood leads. Despite the large amount of scatter, the relationship appears to be linear and to pass close to the origin. A few points fall some distance above the line and appear anomalous. We investigated whether the errors associated with the determinations of lead in whole blood and serum could by themselves account for the scatter in a plot of blood lead against serum lead. To do this we 7rst noted that the calculation of serum lead concentration is derived from the relationship c"x!b, where c is the amount of lead in the serum sample, x the amount of lead processed, and b is the blank. If we assume that the error in c is dominated by that in the blank and if we write b/x"f, we can show that
where CV is the coef7cient of variation. We took that of the blank to be 0.6 and used the above relationship to calculate the standard deviation of each serum lead determination. To estimate the standard deviation of the blood lead concentration measurements we plotted the absolute value of the difference between pairs of
FIG. 2.
Plot of serum lead concentration vs blood lead concentration for the 73 subjects reported in this paper. A line 7tted to the points has equation y"0.00246#0.00236x (r"0.82). ' " Fasting subject with unspeci"ed clotting time from Manton and Cook (1984) ; ᮀ this work, the same subject with sample immediately centrifuged; , the same subject, sequentially drawn sample left to clot for 5.5 h. The point for the subject eating ad libitum (Manton and Cook, 1984) has an ordinate of 0.45 g Pb/L and falls out of the 7eld of the diagram. For reference, the curves obtained by SchuK tz et al. (1996) and for Hernandez-Avila et al. (1998) as calculated by us are also shown. The curves of both groups of workers were de7ned down to blood lead concentrations of 23 g/dL so that at the lower end of their ranges their observations overlap with ours.
FIG. 3.
Plot of blood lead concentration vs the ratio of serum lead to blood lead concentration. For reference, the relationships reported by Bergdahl and Skerfving (1997) and Hernandez-Avila et al. (1998) are also shown. measurements against blood lead concentration and obtained a line of slope indistinguishable from zero. Taking this to imply that all measurements had identical standard deviations we made a pooled estimate of the variance by means of the formula
, where d G is the difference between the i'th pair of measurements and k is the total number of pairs. We obtained a value of 1.64 g Pb/L for the standard deviation, which we used as a blanket error. We then ran the data and the 1 estimates of error associated with each point through GEODATE (Enlington and Harmer, 1999), a straight-line-7t-ting program based on the method of York (1969) . The program yields a quantity called the mean square of the weighted deviates (MSWD) that can be tested as an F variate. A problem that occurs is the choice of the degree of freedom to use for the numerator. Although we made only one measurement of each subject's serum lead concentration it was based on at least 10 sets of isotopic ratios, which justi7es using 10, but the blood lead concentrations were based on a pair of measurements, which justi7es 2. We were conservative and took the lesser number. The critical value (F 0.5, 2, 71 ) is 3.13, which when compared to the MSWD of 22.6 indicates that there are sources of variation other than those brought about by analytic error. As the source of error in determining blood lead concentration is well understood, we attribute the excess variation to the serum lead variable, which we can reasonably explain as being person to person variations in the distribution of lead between plasma and the red cells. This being so, we conclude that the total variation in serum lead greatly exceeds that in blood lead and that we are justi7ed in treating the data set as a standard least squares regression, i.e., one in which x is known without error. (We did not use GEODATE because that program was developed to model open rock systems and proceeds to augment errors in both x and y until the critical F value is obtained.)
The line shown in Fig. 2 is, therefore, a standard least squares 7t. Its equation is y" 0.00030#0.00241x and the Pearson correlation coef7cient is 0.83.
Fraction of Pb in Serum
The ratio of serum lead to blood lead is plotted against blood lead in Fig. 3 . Eight samples have ratios greater than 0.004 but the remainder fall between 0.001 and 0.004 and show no obvious dependence on blood lead concentration. This lack of dependence allow us to present the ratios in histogram form (Fig. 4) . A well-de7ned mode lies between 0.0016 and 0.0022, whereas the arithmetic and geometric means are 0.0025 and 0.0023, respectively.
DISCUSSION
Previous Measurements by Thermal Ionization Mass Spectrometry
In contrast to the earlier study of Manton and Cook (1984) , we have found a linear serum lead to blood lead relationship that passes through the origin. We reject Smith et al.'s (1998) explanation that Manton and Cook's (1984) samples were left to stand too long, causing lead to diffuse from the clot to the serum, because we demonstrated that our techniques do not produce this effect. We also reject Schu K tz et al. 's (1996) explanation of contamination because in each study we obtained similar values for the serum lead to blood lead ratio and the renal clearance of lead from plasma (Table 2) . We consider valid the explanation previously given that high values resulted from disequilibrium caused by dietary lead failing to bind immediately to the red cells. The fact that we and others do not observe this today results from lead levels in food having fallen over the past 20 years, so that insuf7cient lead is now being absorbed from dietary sources to materially affect equilibrium between plasma and red cells. We note that Manton and Cook's (1984) measurements on a fasting subject lie close to the line obtained in this work (Fig. 2) , implying that the serum lead to blood lead relationship that they postulated is essentially correct for blood leads between zero and 100 g Pb/L. Whether their postulate of a serum lead concentration of 2.0 g/L at a blood lead of 500 g/L is accurate is unknown, because they let their samples clot for unspeci7ed times, but at so high a blood lead concentration the effect of dietary lead is small, so their estimate is probably low rather than high. Because it serves as a useful reference, Manton and Cook's idealized curve is shown in Fig. 5 . It was produced by the 7tting of a parabola to the points (0, 0), (100, 0.2) and (500, 2).
Measurements by ICP Mass Spectrometry
The log-linear relationship between plasma lead and blood lead concentration reported by Schu K tz et al. (1996) log(plasma Pb)"0.00277;blood Pb!0.77 may also be expressed by the function y" 0.17 e 0.00638x , where y is plasma lead and x is blood lead concentration (Fig. 5) . When plotted, this curve lies above the 7eld of our measurements (Fig. 2) . The LEAD CONTENT OF BLOOD SERUM ?These values were obtained by digitizing the curve shown in Fig. 1A of Hernandez-Avila et al. (1998). nonzero intercept of 0.17 g Pb/L is far less than Manton and Cook's (1984;  Fig. 2 ) intercept of 0.6 g Pb/L, but with increasing blood lead concentration the functions published by their laboratory cross Manton and Cook's (1984;  Fig. 2 ) original curve and then diverge more and more from it. For example, at a blood lead concentration of 750 g/L the values reported are 6.5 g Pb/L for serum by Manton and Cook (1984) and 11.6 g Pb/L for plasma by Bergdahl et al. (1999) , whereas at a blood lead concentration of 1000 g/L the values for serum and plasma reported by each group are 13 and 45 g Pb/L.
Since Hernandez-Avila et al. (1998) published no equation relating plasma lead to blood lead concentration we recovered the function by enlarging and then digitizing points on their published log}log curve (Hernandez-Avila et al., 1998, Fig. 1A) . The values are shown in Table 3 . We found plasma lead and blood lead to be closely 7tted (r"0.9999) by the parabola
where y is plasma lead and x is blood lead concentration (Fig. 5) . The curve falls above Manton and Cook's (1984) idealized curve but intersects that of Schu K tz et al. (1996) at two places (Fig. 5) .
It is dif7cult to explain why these two studies by ICP mass spectrometry differ not only from each other but also from Manton and Cook's (1984) original work and the 7ndings reported in this paper. The 8attening of Schu K tz et al. 's (1996) curve below blood lead concentrations of 200 g/L and the nonzero intercept are consistent with background contamination that was not corrected for, but with increasing concentrations its effect would diminish and their curve should merge into Hernandez-Avila et al. 's (1998) . That it does not do so suggests that other factors are at work. Clearly there is a need for interlaboratory standards and, as Smith et al. (1998) have pointed out, a need for agreement on appropriate clotting times.
Fraction of Pb in Serum
Both Hernandez-Avila et al. (1998) and Schu K tz et al. (1996) 7tted logarithmic functions to their plots of blood lead against plasma lead and straight lines to plots of blood lead against the plasma lead to blood lead ratio. Not only is this incorrect but, as we shall show in this section, it also leads to errors of interpretation. To avoid unnecessary repetition we shall refer to the relationship between blood lead and plasma lead as the plasma function and that between blood lead and the ratio of plasma to blood lead as the plasma fraction function. We shall use polynomials because they can be expressed in forms that pass through the origin and thus describe the fundamental relation that when the lead content of blood is zero that of plasma or serum is also zero. They are easily manipulated, many functions are approximated by polynomials and, indeed, the range of physical measurements is seldom large enough or their quality good enough to distinguish between, say, an exponential function and a fourth-order polynomial.
If it is assumed that the plasma function is of the form y"f(x), where f(x) is an nth-order polynomial that passes through the origin, it follows that the plasma fraction function is of the form y"f (x)/x, which like the 7rst derivative of the plasma function will be a polynomial of order n!1. This relationship immediately places restrictions on the functions that may be 7tted to the plasma fraction function. If the plasma function is best 7tted by a quartic, the line 7tted to the plasma fraction function must be a cubic and so on. In particular, 7tting a straight line to the plasma fraction function is justi7ed only if it is known that the plasma function is parabolic. It is also important to note that when x"0 the values of f (x)/x and of the 7rst derivative of f(x) are identical because at this point and this point only both give the slope of y"f(x). This value in turn equals the coef7cient of the x term in the polynomial y"f(x). In other words, the fraction of lead in plasma given by the y intercept of the plasma fraction plot is identical to the coef7cient of the blood lead term raised to the 7rst power in a polynomial expressing plasma lead as a function of blood lead raised to various powers. We give some examples.
In the case of the plasma function being a straight line passing through the origin with equation y"bx, both y"f(x)/x and dy/dx are independent of x and equal b. We illustrate this with our results. We found the plasma function to be a line with slope 0.00241 (Fig. 2) and the independently calculated fraction of lead in serum to be 0.00251 (Fig. 4) .
In the case of the plasma function being the parabola y"bx#cx 2 , the 7rst derivative is dy/dx"b#2cx and the plasma fraction function is y"b#cx. Thus, both are straight lines intersecting the y axis at b and having slopes differing by a factor of two. If, however, the plasma function does not pass through the origin but has a small positive intercept a on the y axis, the plasma fraction function contains an additional term a/x. As x approaches zero this term increases until at x"0 the function equals in7nity. On the other hand, the term becomes negligible once x attains a suf7ciently large value. We illustrate this with the results of HernandezAvila et al. (1998) . The parabolic relationship that we obtained from their published curve yields the plasma fraction function
It is clear that x has to be greater than 100 g Pb/L for the 7rst term in the plasma fraction function to be less than 10% of the second term. In Fig. 6 we plot against blood lead Hernandez-Avila et al. 's (1998) values of the plasma lead to blood lead ratio (Table  3) . We 7tted a line to points with abscissas greater than 100 g Pb/L. Its slope is 7.24;10\ 6 and its intercept is 0.00262, both of which are close to the values predicted. Also plotted on the diagram is the line that Hernandez-Avila et al. (1998, Fig. 2A) 7tted to a set of 25 points in a plot of blood lead against the ratio plasma lead to blood lead. Since 15 of these had abscissas less than 100 g Pb/L and 5 had between 100 and 200 g Pb/L it is not dif7cult to imagine how such a line could be obtained when the nature of the underlying function is obscured by the scatter of the points.
We now turn to Schu K tz et al. (1996) who obtained a plasma function described by the exponential y"0.17 e 0.00638x . Only the 7rst two terms of its expansion need be written down y"0.170#1.08;10\ 3 x# 2 to see that the plasma fraction function contains a term 0.17/x that will in8uence the function as long as x is less than 500 g Pb/L. In Fig. 7 we have plotted discrete points of the function y"0.17 e 0.00638x /x and show the line 7tted by Bergdahl and Skerfving (1997, Fig. 1 ) to a plot of blood lead against the plasma lead to blood lead ratio. Again it is easy to imagine how such a line could be drawn through points randomly scattered about this curve, although we remark that the distribution of points in their plot clearly shows the U shape of the underlying function.
The close agreement (Fig. 3) between the plasma fraction functions reported by Bergdahl and Skerfving (1997) and Hernandez-Avila et al. (1998) must be fortuitous. The appropriate values for the fractions of Pb in plasma when lead in blood becomes vanishingly small are given by the coef7cients of the x term of the polynomial forms of their plasma functions, 0.11% in the case of Bergdahl and Skerfving (1997) and 0.25% in the case of Hernandez-Avila et al. (1998) , which is very close to our value. The relative values may also be estimated from the slopes of their functions at the point of crossing the y axis. See Figs. 2 and 5.
The coef7cient of the blood lead term in the plasma function is independent of any uncertainty in the analytical blank that will cause the function
FIG. 7.
The relationship between blood lead concentration and the ratio of plasma lead to blood lead when the curve relating blood lead and plasma lead is y"0.17 e 0.00638x as obtained by Schu K tz et al. (1996) . Discrete points of the function y"0.17 e 0.00638x /x are shown. The dashed line is that 7tted by Bergdahl and Skerfving (1997) to their observations. not to pass exactly through the origin. It is, therefore, a better measure of the fraction of lead in serum or plasma than the intercept of the plasma fraction function which will be affected by a nonzero intercept of the plasma function.
Signi=cance of Serum Fraction
Insofar as the concentration of lead in serum changes linearly up to a blood lead concentration of at least 60 g Pb/L the erythrocytes are behaving analogously to an ion exchanger binding with an ion in dilute concentration in an external aqueous medium. To extend the analogy we de7ne a distribution coef7cient, D, as the ratio of the concentration of lead in the erythrocytes, PbE, to that in plasma, PbP. Since the plasma lead concentration is much less than that of whole blood, the erythrocyte lead concentration is directly related to the whole blood lead concentration, PbB, through the fractional hematocrit, Hct, i.e., PbE"PbB/Hct.
If we divide both sides by PbP and remember that PbP/PbB is the slope of our plasma function we get D"1/(0.00241Hct) which leads to a value of 1;10 for a hematocrit of 0.42. This 7gure expresses in the form of a distribution coef7cient the effectiveness with which the erythrocytes are able to scavange contaminating lead from blood plasma, leaving the physiologic lead content of the plasma virtually unaltered.
The analogy with an ion exchanger should not be taken too far, however, because there is ample evidence that the building of lead to the erythrocytes is slow and dependent on the form or source of the lead. This was 7rst apparent from the work of Chamberlain et al. (1975) who showed that over the 7rst 4 h following an intravenous saline injection of Pb large amounts of the isotope appeared in urine. Along the same lines, J. H. Graziano and W. I. Manton (unpublished measurements) observed that immediately after a subject (subject 1 of Graziano et al., 1996) had drunk sherry labeled with stable isotopes the isotopic ratios of lead in her urine were dominated by those of the wine, and at 24 h, even though the absorption of lead was complete, the lead in her blood and urine were still isotopically distinct. Measurements of plasma lead concentration suggest that the binding of dietary lead to the erythrocytes is also not immediate. For example, Manton and Cook (1984) found that the serum lead concentration and urinary lead excretion measured in a subject eating freely were twice those of when the same subject was fasting. (See Table 2 and Fig. 2 .) Lead released from bone appears to behave in a similar manner, except that it enters plasma continuously rather than periodically. For example, Cake et al. (1996) found in active lead workers that serum lead appeared to correlate more strongly with in vivo bone lead measurements than with blood lead, and Tsaih et al. (1999) found that in middle-aged to elderly men urinary excretion correlated better with bone lead than with blood lead. In this work we observed that the serum of a sample left to clot for more than 5 h had half the concentration measured in a sample that was immediately centrifuged, which may be taken to mean that half the lead in plasma circulating in vivo is out equilibrium with the erythrocytes. As the subject had been fasting, bone is a likely source for this lead. It is of interest that the 206 Pb/ 207 Pb ratios of his blood and urine were different (1.1617 and 1.1588, respectively) with that of urine shifted toward the ratio of his skeleton which is known to contain Australian-type lead (Manton, 1985) . plasma lead measurements was presented by W. I. Manton at the EPA Workshop on Lead Model Development held in Durham, North Carolina, June 14}17, 1999. 
